» Articles » PMID: 8551620

The Envelope Glycoprotein of Human Immunodeficiency Virus Type 2 Enhances Viral Particle Release: a Vpu-like Factor?

Overview
Journal J Virol
Date 1996 Feb 1
PMID 8551620
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

The Vpu protein is a human immunodeficiency virus type 1 (HIV-1)-specific accessory protein that is required for the efficient release of viral particles from infected cells. Even though HIV-2 does not encode Vpu, we found that this virus is nevertheless capable of efficiently releasing virus particles. In fact, the rate of virus release from HeLa cells transfected with a full-length molecular clone of HIV-2, ROD10, was comparable to that observed for the vpu+ HIV-1 NL4-3 isolate and was not further enhanced by expression of Vpu in trans. However, consistent with previous observations showing that HIV-2 particle release is Vpu responsive in the context of HIV-1/HIV-2 chimeric constructs; exchanging the gag-pol region of NL4-3 with the corresponding region from pROD10 rendered the resulting chimeric virus Vpu responsive. Our finding that the responsiveness of HIV-2 particle release to Vpu is context dependent suggested the presence of a Vpu-like factor(s) encoded by HIV-2. Using chimeric proviruses encoding HIV-2 gag and pol in the context of the HIV-1 provirus that were coexpressed with subgenomic HIV-2 constructs, we found that the HIV-2 envelope glycoprotein had the ability to enhance HIV-2 particle release with an efficiency comparable to that of the HIV-1 Vpu protein. Conversely, inactivation of the HIV-2 env gene in the original ROD10 clone resulted in a decrease in the rate of viral particle release to a level that was comparable to that of Vpu-deficient HIV-1 isolates. Providing the wild-type envelope in trans rescued the particle release defect of the ROD10 envelope mutant. Thus, unlike HIV-1, which encodes two separate proteins to regulate virus release or to mediate viral entry, the HIV-2 Env protein has evolved to perform both functions.

Citing Articles

Glucosylceramide and galactosylceramide, small glycosphingolipids with significant impact on health and disease.

Reza S, Ugorski M, Suchanski J Glycobiology. 2021; 31(11):1416-1434.

PMID: 34080016 PMC: 8684486. DOI: 10.1093/glycob/cwab046.


Role of the Ubiquitin Proteasome System (UPS) in the HIV-1 Life Cycle.

Rojas V, Park I Int J Mol Sci. 2019; 20(12).

PMID: 31248071 PMC: 6628307. DOI: 10.3390/ijms20122984.


Hijacking of the Ubiquitin/Proteasome Pathway by the HIV Auxiliary Proteins.

Seissler T, Marquet R, Paillart J Viruses. 2017; 9(11).

PMID: 29088112 PMC: 5707529. DOI: 10.3390/v9110322.


Expression of HERV-K108 envelope interferes with HIV-1 production.

Terry S, Manganaro L, Cuesta-Dominguez A, Brinzevich D, Simon V, Mulder L Virology. 2017; 509:52-59.

PMID: 28605635 PMC: 5538378. DOI: 10.1016/j.virol.2017.06.004.


Proteolysis of mature HIV-1 p6 Gag protein by the insulin-degrading enzyme (IDE) regulates virus replication in an Env-dependent manner.

Hahn F, Schmalen A, Setz C, Friedrich M, Schlosser S, Kolle J PLoS One. 2017; 12(4):e0174254.

PMID: 28388673 PMC: 5384750. DOI: 10.1371/journal.pone.0174254.


References
1.
Maldarelli F, Chen M, Willey R, Strebel K . Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein. J Virol. 1993; 67(8):5056-61. PMC: 237897. DOI: 10.1128/JVI.67.8.5056-5061.1993. View

2.
Friborg J, Ladha A, Gottlinger H, Haseltine W, Cohen E . Functional analysis of the phosphorylation sites on the human immunodeficiency virus type 1 Vpu protein. J Acquir Immune Defic Syndr Hum Retrovirol. 1995; 8(1):10-22. View

3.
Vincent M, Raja N, Jabbar M . Human immunodeficiency virus type 1 Vpu protein induces degradation of chimeric envelope glycoproteins bearing the cytoplasmic and anchor domains of CD4: role of the cytoplasmic domain in Vpu-induced degradation in the endoplasmic reticulum. J Virol. 1993; 67(9):5538-49. PMC: 237957. DOI: 10.1128/JVI.67.9.5538-5549.1993. View

4.
Purcell D, Martin M . Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J Virol. 1993; 67(11):6365-78. PMC: 238071. DOI: 10.1128/JVI.67.11.6365-6378.1993. View

5.
Lenburg M, Landau N . Vpu-induced degradation of CD4: requirement for specific amino acid residues in the cytoplasmic domain of CD4. J Virol. 1993; 67(12):7238-45. PMC: 238186. DOI: 10.1128/JVI.67.12.7238-7245.1993. View